Publication | Closed Access

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineInfinity StudyGastroenterologyPathologySurgeryGastroesophageal Junction AdenocarcinomaCancer GeneticsOncologyNon-operative Management StrategyCancer Research